Does Insurance Cover Testosterone Treatments?

Disclosure: PrescribedRX sells its own treatments, so we compete with some of the companies covered here, and we may earn affiliate commissions.

MEDICAL DISCLAIMER This content is for informational purposes only and does not constitute medical advice. Consult a licensed physician before starting any hormone therapy or treatment.

Finding a treatment plan that finally addresses low testosterone feels like a massive relief, until you see the price tag. Whether you’re looking at gel, injections, or pellets, the long-term nature of Testosterone Replacement Therapy (TRT) makes insurance coverage a financial necessity rather than a luxury.

Navigating the “medical necessity” maze in 2026 isn’t just about having low numbers on a lab report; it’s about meeting specific, often rigid, criteria set by major carriers like Aetna, BCBS, and Cigna. A single missing lab value or a specific diagnosis code can be the difference between a standard $15 copay and a $400 monthly out-of-pocket expense.

This guide breaks down the current landscape of TRT coverage. 

The Short Answer: Is TRT Covered by Insurance?

Yes, most major health insurance plans can cover testosterone replacement therapy, but only when it is documented as medically necessary. That generally means two early-morning blood tests showing total testosterone below your insurer’s threshold (commonly 300 ng/dL, though some plans use 250 ng/dL), plus documented symptoms of hypogonadism such as low libido, fatigue, erectile dysfunction, or reduced muscle mass.

Coverage rules are similar across Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, though each carrier has its own prior authorization process, formulary tiers, and preferred medications. Medicare can cover TRT under Part B (for clinician-administered injections) or Part D (for self-administered prescriptions), but it excludes coverage for age-related (late-onset) low testosterone unless there’s an identifiable underlying disorder. Medicaid coverage varies by state.

If insurance won’t cover your therapy, cash-pay testosterone is more affordable than many men assume. Generic injectable testosterone cypionate can run as low as $30 to $100 per month at retail pharmacies, while brand-name gels, patches, and pellets can cost several hundred dollars per month.

Prior Authorization and Step Therapy

Most insurers require prior authorization before they’ll cover testosterone. Your physician submits the request along with your labs, symptom documentation, and proposed treatment plan. Approval can take anywhere from a few days to several weeks, depending on the carrier and how complete the submission is.

Some plans also apply step therapy, which means you may need to try (and not respond to) a less expensive option such as a generic injection before the plan will cover a more expensive formulation such as a topical gel or long-acting injection. This is one of the most common reasons men shift to cash-pay clinics: the paperwork delays can stretch out treatment for weeks.

Considering TRT? Get a plan built around your labs.

Take the 2-minute assessment with a licensed PrescribedRX provider. No pressure, no obligation.

Start Your TRT Assessment

Explore plans: Injectable Testosterone · Testosterone Cream · Enclomiphene

Carrier-by-Carrier Breakdown: Aetna, BCBS, Cigna, UnitedHealthcare

Each major carrier publishes its own clinical policy bulletin or formulary coverage guideline for testosterone. Here’s what to expect from the four largest commercial insurers in the United States.

Aetna

Aetna generally covers testosterone replacement therapy when medical necessity is established. According to Aetna’s clinical policy bulletins, that typically means two confirmed low morning testosterone readings, documented symptoms, and an evaluation of potential underlying causes. Aetna explicitly considers age-related (late-onset) hypogonadism a general exclusion, not one limited to particular formulations. Clinical Policy Bulletin 1014, which covers testosterone cypionate (a short-acting ester) lists “age-related hypogonadism or late-onset hypogonadism” among uses it considers experimental, investigational or unproven, and Aetna’s pharmacy prior-authorisation policy requires that “the requested drug is NOT being prescribed for age-related hypogonadism”.

Aetna also applies cost-effectiveness rules. For example, the plan may cover generic testosterone cypionate readily but require evidence of contraindication, intolerance, or treatment failure on cypionate before approving more expensive alternatives. Coverage of topical gels, patches, and pellets varies by plan tier.

Blue Cross Blue Shield (BCBS)

BCBS is a federation of independent plans, so coverage details can differ between states and product lines. That said, most BCBS plans follow the same general framework: documented hypogonadism with two low morning testosterone readings, clinical symptoms, and prior authorization. Many BCBS plans will preferentially cover generic injectable testosterone over brand-name gels, with brand formulations typically placed on higher cost-sharing tiers.

Because BCBS plans are state-specific, you’ll want to check your individual plan’s formulary and prior authorization requirements directly, either through your member portal or by calling the number on the back of your card.

Cigna

Cigna’s published coverage policies for injectable and topical testosterone require a confirmed diagnosis of hypogonadism, including at least two early-morning testosterone tests showing low levels, plus an evaluation of the cause of the deficiency. Cigna often requires prior authorization and ongoing monitoring to maintain coverage.

Cigna plans can vary widely. Some cover multiple delivery methods (injections, gels, patches), while others may limit coverage to the most cost-effective option. As with most insurers, your provider’s documentation is the deciding factor. Incomplete prior authorization submissions are a leading cause of denials.

UnitedHealthcare (UHC)

UnitedHealthcare generally covers TRT when its medical necessity criteria are met: documented hypogonadism confirmed by two separate early-morning testosterone tests, clinical symptoms, and evaluation of the cause. UHC may require that reversible causes (such as obesity, sleep apnea, or certain medications) be addressed before or alongside TRT.

Coverage through UHC can differ by plan type (HMO, PPO, EPO). Many UHC plans require prior authorization, and topical gels may sit on a higher cost-sharing tier than generic injectables. Repeat lab monitoring is also typically required to continue coverage.

Quick Reference: What Each Major Carrier Typically Requires

Carrier	Typical Coverage Requirements	Common Restrictions
Aetna	Two morning testosterone readings below threshold, documented symptoms, evaluation of underlying causes.	Excludes age-related (late-onset) hypogonadism for some long-acting injectables; prefers generic cypionate.
Blue Cross Blue Shield	Confirmed hypogonadism, prior authorization, ongoing monitoring; rules vary by state plan.	Brand-name gels and pellets often on higher tiers; state-by-state variation.
Cigna	Two early-morning low testosterone readings, symptom documentation, evaluation of cause, prior authorization.	Some plans limit coverage to the most cost-effective formulation; incomplete PAs lead to denials.
UnitedHealthcare	Confirmed hypogonadism, two morning tests, symptoms, evaluation of reversible causes.	May require addressing obesity, sleep apnea, or medication causes first; topical gels on higher tiers.

If you are interested in exploring specific providers after reviewing your coverage options, check out our best TRT clinics roundup.

Does Medicare Cover TRT?

Yes, Medicare can cover testosterone replacement therapy, but the rules are more layered than with commercial plans. Coverage flows through different parts of Medicare depending on how the medication is administered.

Medicare Part B vs. Part D

Part B generally covers testosterone that is administered by a clinician in an outpatient setting, such as an in-office injection. Under Part B, Medicare typically pays 80% of the approved cost after you meet your deductible, and you’re responsible for the remaining 20% coinsurance.

Part D covers self-administered prescription forms of testosterone, including injections you give yourself, topical gels, and patches, when the medication is on your specific plan’s formulary. 

Costs under Part D vary based on the plan’s tier system, deductible, and any prior authorization rules. Starting in 2025 and continuing into 2026, Part D plans include an annual out-of-pocket cap, which provides meaningful financial relief for people who use TRT long-term.

What Medicare Excludes

An important exception: Medicare generally does not cover TRT for late-onset (age-related) hypogonadism without a clearly documented underlying disorder of the testicles, pituitary gland, or brain. In practical terms, if your low testosterone is attributed primarily to normal aging rather than a specific medical condition, Medicare may decline coverage.

Medicare also excludes coverage for individuals with prostate or breast cancer, and may exclude coverage following certain recent medical events. Prior authorization and lab documentation of medical necessity are typically required for any Medicare-covered TRT prescription.

Medicare Advantage Plans

Medicare Advantage (Part C) plans must cover at least what original Medicare covers, but their out-of-pocket structures differ. In 2025, in-network out-of-pocket limits for Medicare Advantage are $9,350, with a combined in-network and out-of-network limit of $14,000. Many Medicare Advantage plans also use evidence-based criteria for reviewing TRT requests, which can either streamline approvals or add additional documentation steps.

ALSO READ: How to Get TRT Online

What About Medicaid?

Medicaid coverage for TRT is set by each state, so what’s covered in one state may be denied in another. In most states, medically necessary TRT is covered when there is documented hypogonadism (confirmed by lab results and symptoms), but prior authorization is almost always required, and state formularies often favor lower-cost formulations such as injectable testosterone over branded gels or pellets.

If you have Medicaid, your best move is to call your state’s Medicaid pharmacy program directly, or have your provider verify formulary status and prior authorization rules before submitting a prescription. Coverage for gender-affirming hormone therapy under Medicaid has also expanded in many states but remains state-specific.

Key Variables That Affect Whether Insurance Will Cover Testosterone

Even within the same insurance carrier, two people can end up with very different coverage outcomes. A handful of factors usually decide which way the decision goes.

1. Your Lab Values and How They Were Drawn

Insurers want morning testosterone draws, typically between 7 and 11 a.m., on two separate days. Levels naturally fluctuate throughout the day, peaking in the morning. An afternoon draw that shows low testosterone may not satisfy your insurer’s medical necessity criteria, even if you’re symptomatic.

2. The Documented Cause of Low Testosterone

Carriers generally cover TRT more readily when there’s a clear primary cause (testicular failure, Klinefelter’s syndrome) or secondary cause (pituitary or hypothalamic dysfunction). Coverage may be more difficult to secure when the diagnosis is age-related or idiopathic low testosterone, particularly under Medicare.

3. Your Plan Type and Formulary

HMO plans tend to require referrals and stricter prior authorization. PPO plans usually offer more flexibility but may still apply step therapy. Your formulary will dictate which formulations are covered and at what tier, which directly affects your copay.

4. Whether Reversible Causes Were Addressed

Some insurers require that reversible causes of low testosterone, such as obesity, untreated sleep apnea, opioid use, or certain prescription medications, be addressed before approving long-term testosterone therapy. If your provider hasn’t documented this evaluation, expect questions during prior authorization review.

Why an Online TRT Clinic That Accepts Insurance Is Hard to Find

Telehealth hormone care grew up on the subscription model, and that was a deliberate business decision rather than an accident. A flat monthly fee covering the consult, the medication, and sometimes the lab work is simple to advertise, simple to forecast, and simple to operate. Billing insurance is none of those things. It requires credentialing with each carrier in each state, staff who can assemble prior authorization packets, and a process for working denials when they come back. For a company shipping vials to men in forty states, that overhead is significant.

The result is a market split in an awkward way. Search for insurance TRT online and most of what comes back are general telemedicine companies that treat everything from sinus infections to high blood pressure, with hormone care as one line item among many. 

The platforms with the deepest hormone protocols, the ones that run a full panel and adjust based on how you feel rather than a single number, are usually cash pay. Directories that track the space put the count of hormone platforms billing insurance directly in the single digits out of dozens listed, though those lists shift as companies enter and leave the market.

None of that makes insurance irrelevant to your costs. It means the coverage question breaks into pieces. Your plan may not pay the clinic, but it may still pay for the blood work, for the medication itself if you fill it at a retail pharmacy, or for follow-up visits with your own physician. Men who treat this as all or nothing tend to leave money on the table. 

For background on how treatment itself works before you get into the billing weeds, The Complete Guide to TRT in 2026 covers the clinical side in more depth.

What Your Plan Requires Before It Pays

Coverage criteria are more consistent across carriers than most people assume. Getting TRT covered by insurance comes down to satisfying the same short list at nearly every major payer, which is why denials tend to cluster around the same handful of gaps.

A diagnosis, not a description of how you feel

The Endocrine Society restated its position on testosterone therapy in July 2026, and one line matters more than any other for billing purposes: symptoms alone are not diagnostic of hypogonadism. Low energy, reduced libido, and flat mood are common in aging men and have many possible causes. The Society advises providers to rule out reversible contributors first, including obesity and medications such as corticosteroids or opioids.

Insurers apply the same logic. What they want in the file is a documented hypogonadism diagnosis, commonly coded as E29.1, supported by both symptoms and lab values. A symptom questionnaire filled out on a clinic website will not carry a claim on its own. 

The Society also noted that when hypogonadism is attributed to being overweight or obese, with a body mass index above 27 and no other identified cause, weight loss is typically the first line approach. Plans increasingly reflect that view, which is one reason otherwise reasonable requests get pushed back.

Two early morning blood draws, not one

Testosterone swings across the day and from one day to the next, and it can be suppressed by food and glucose. Because of that, published guidance calls for at least two early morning fasting measurements before a diagnosis is made, with a common clinical threshold near 300 ng/dL. Most carriers have written that requirement straight into their medical policy.

A second, quieter problem with lab work catches men off guard. Testosterone assays are not all standardized, and the same blood sample can read low at one laboratory and normal at another depending on the method used. The Endocrine Society encourages the use of assays certified through the Centers for Disease Control and Prevention Hormone Standardization Program, noting that non-standardized testing drives both over-diagnosis and under-diagnosis. 

If an online program screens you with a finger-stick kit rather than a venous draw at a major reference laboratory, those results may not satisfy your plan even when the clinic is happy to accept them.

Prior authorization

Assume you will need it. Your prescriber submits the labs, the diagnosis, and clinical notes, and the plan reviews the request before agreeing to pay. Turnaround runs from a few days to a few weeks, and incomplete submissions are a common source of delay. If your prescriber does not routinely file these for testosterone, ask who on their staff does.

The rules shifted here at the start of 2026. Under the Centers for Medicare and Medicaid Services Interoperability and Prior Authorization final rule, Medicare Advantage plans, Medicaid and CHIP programs, and qualified health plans on the federal exchange must now give a specific reason for a denial rather than a vague statement about medical necessity, and must publicly post their authorization approval, denial, and appeal figures.

One caveat matters a great deal here: those provisions apply to medical items and services, not to drugs. Testosterone filled at a pharmacy runs through your pharmacy benefit and sits outside that rule. Regulators proposed extending similar requirements to drug authorizations in April 2026, but that proposal has not been finalized.

Step therapy and where your formulation sits

Even approved patients get steered toward particular products. Generic injectable testosterone cypionate is the default on most formularies and usually sits at a low tier. Gels, patches, and pellets more often land on a non-preferred tier or trigger step therapy, meaning you have to try the cheaper option first and document that it did not work for you. 

Compounded preparations, which a number of telehealth programs favor, are frequently excluded outright because they are not FDA approved products. If your clinic dispenses only compounded formulations, reimbursement for the medication is unlikely no matter how clean your diagnosis is.

The Three Payment Models You Will Run Into

Every online TRT clinic that accepts insurance falls into the first category below, but the other two can still lower what you pay. Knowing which model you are looking at tells you immediately what questions to ask.

Direct billing

The clinic is in network with your carrier, submits claims on your behalf, and you pay a copay. These tend to be broad telehealth companies rather than hormone specialists. Whether they work for you depends on which carriers they contract with and which state you live in, so verify your specific plan instead of trusting a general claim that the company takes insurance. The tradeoff is depth. A generalist platform may prescribe more conservatively, run a narrower panel, or refer you out to a specialist for anything complicated.

Cash pay with a superbill

This is the middle ground and the one men most often miss. You pay the clinic directly, then receive an itemized receipt listing diagnosis and procedure codes that you submit to your carrier yourself for out of network reimbursement. Whether anything comes back depends entirely on your out of network benefits, and plenty of plans carry a separate and much higher out of network deductible. Medicare does not reimburse out of network services at all, so a superbill is of no use to anyone on Medicare. Ask whether superbills are available before you enroll rather than after.

Cash pay only

A flat monthly fee, nothing to submit, no claims to chase. Simplicity is the product, and for men who value predictable costs over reimbursement it is a defensible choice. Even here, though, parts of your care may still be billable. 

Programs that route blood work through a national reference laboratory sometimes allow you to run that testing under your own benefits, and a prescription written to an outside retail pharmacy can often be filled with generic testosterone cypionate for a fraction of what a bundled subscription implies. Ask both questions directly, because neither is usually advertised.

Working out what you would actually pay under each model? Our TRT cost guide breaks down monthly totals by delivery method, and our roundup of the cheapest online TRT clinics covers the lower end of the cash pay market.

What Gets Denied Even When You Have Coverage

Coverage for the diagnosis does not mean coverage for everything on your treatment plan. These are the gaps that generate most of the surprise bills.

• Treatment when your labs read normal. This is the single most common gap. If your total testosterone lands above the plan threshold, the plan treats therapy as elective regardless of how you feel, and men in this position generally end up paying cash.
• Compounded testosterone and pellet implants. Both are commonly excluded, the first because compounded preparations are not FDA approved products and the second because it is often classified as a non-preferred delivery method.
• Ancillary prescriptions. Medications used alongside testosterone to manage estrogen or support fertility are frequently prescribed off label for that purpose, which means separate authorization and a higher denial rate.
• Membership and program fees. The subscription itself is generally not a covered medical expense even when the medication is.
• Monitoring you did not know was required. Plans that cover therapy usually expect periodic follow-up labs, and some make continued coverage conditional on them being done on schedule.

If you want the coverage question examined on its own terms, our guide on when insurance covers TRT goes deeper on how requirements differ from one plan type to the next.

HSA and FSA Dollars: The Path Most Men Skip

Even when a plan will not pay a cent toward a cash pay program, pre-tax accounts usually will. Testosterone is an eligible expense for a health savings account, a standard flexible spending account, or a health reimbursement arrangement when it is prescribed. It is not eligible under a limited purpose FSA or a dependent care FSA, which is a distinction worth checking before you assume your card will work.

That eligibility generally extends beyond the medication to lab work and consultation fees when a valid prescription is attached to the expense. Paying with pre-tax dollars effectively reduces the cost by your marginal tax rate, which on a recurring monthly expense adds up over a year. It is not the same thing as coverage, but it is real money and it requires no approval from anyone.

Two cautions. Program and membership fees sit in a grayer area than the medication itself, so confirm with your account administrator rather than assuming. And keep documentation: the prescription, itemized receipts, and a letter of medical necessity from your prescriber. IRS Publication 502 is the reference document if you want to check a specific expense yourself.

If Your Claim Comes Back Denied

A denial is an opening position, not a verdict, and a large share of them turn on paperwork rather than clinical judgment. The usual causes are a missing second lab result, a diagnosis code that was never entered, an authorization that was never filed, or a request for a formulation the plan expects you to try later rather than first. 

Every one of those is fixable with better documentation, which is why appeals succeed more often than most men assume.

1. Get the specific reason in writing. Plans covered by the 2026 federal requirements have to state it plainly rather than citing medical necessity in the abstract. You cannot fix a denial you cannot read.
2. Ask for a peer to peer review. Your prescriber speaks directly with the plan’s medical reviewer, and these conversations sometimes resolve the matter without a formal appeal.
3. File an internal appeal. Under federal rules you generally have 180 days from the denial notice to file. The plan must decide within 15 days for a prior authorization request and 30 days for care you have already received. Include both morning lab results with dates, the full panel, documented symptoms, and a letter of medical necessity from your prescriber that references published clinical guidance.
4. Request an external review. If internal appeals fail, an independent organization with no relationship to your insurer reviews the case. Standard reviews are decided no later than 45 days after the request, and urgent cases within 72 hours. Your insurer is required by law to accept the outcome.
5. Escalate to your state insurance department. A complaint filed with the state regulator sometimes prompts reconsideration on its own.

Most men never appeal at all, and that is the real reason so many give up and pay cash. If you have the labs and the diagnosis in hand, the paperwork is usually the only thing standing between you and a decision in your favor.

What to Discuss With Your Healthcare Provider

Before you start TRT, a structured conversation with your provider can save you weeks of insurance back-and-forth. Bring a list of questions and be specific about your goals.

• Are my testosterone levels low enough to meet my insurer’s threshold for coverage?
• Were my morning testosterone draws done correctly, and on two separate days?
• Have we ruled out reversible causes like sleep apnea, certain medications, or weight-related factors?
• Which TRT formulation does my plan prefer, and is that the right fit clinically?
• What does the prior authorization process look like, and how long does it typically take?
• If I’m denied coverage, what is the appeals process and how often does it succeed?
• What ongoing labs and monitoring will I need, and how often?

Your provider’s office handles insurance questions regularly. Asking these questions early helps clarify whether you’re a good candidate, what your costs may look like, and whether your plan’s preferred formulation aligns with what’s clinically appropriate for you.

Frequently Asked Questions

Does insurance cover testosterone if my levels are borderline?

Often, no. Most insurers set hard thresholds (commonly 300 ng/dL), and require levels below that on two morning draws. If your levels are between 300 and 400 ng/dL but you have clear symptoms, you may be denied coverage, even though your symptoms warrant treatment. In that case, options include appealing the decision with detailed symptom documentation, requesting additional labs (such as free testosterone or SHBG), or considering cash-pay options.

Does Medicare cover TRT for men over 65 with low testosterone from aging?

Generally, no. Medicare typically excludes coverage for late-onset (age-related) hypogonadism unless an underlying disorder of the testicles, pituitary, or brain is documented. If your bloodwork identifies a specific medical cause, coverage becomes more likely. Otherwise, you may need to consider cash-pay options or Part D coverage with prior authorization.

Will my insurance cover testosterone gels and pellets, or just injections?

Most plans cover generic injectable testosterone with the fewest restrictions. Topical gels, patches, and pellets are often placed on higher cost-sharing tiers, and many plans require step therapy (trying a less expensive option first) before approving these. Brand-name gels like AndroGel are commonly tier 3 or higher with significant copays.

Can I appeal an insurance denial for TRT?

Yes, and appeals are frequently successful when supported by complete documentation. Your provider can submit an appeal letter with your full lab history, symptom checklist, and a clinical rationale tied to published guidelines. The appeals process can take several weeks but is worth pursuing if your symptoms are clearly documented.

How long does prior authorization take for TRT?

It varies by carrier and plan, but most prior authorizations are decided within several days to a few weeks. Incomplete submissions are the most common cause of delays. Making sure your provider includes both lab results and symptom documentation in the initial PA request can prevent unnecessary back-and-forth.

Does insurance cover the labs needed to qualify for TRT?

Usually yes, when your provider orders testosterone testing as part of evaluating documented symptoms. Some plans may require a specific diagnosis code or limit the frequency of testing. Confirm with your provider’s office and your plan’s formulary before scheduling repeat labs.

Is TRT covered by insurance if I’m using it for performance or anti-aging?

No. Insurance does not cover testosterone therapy for performance enhancement, bodybuilding, or general anti-aging purposes. Coverage is contingent on documented hypogonadism with confirmed lab values and clinical symptoms.

What’s the cheapest TRT option if my insurance won’t cover it?

Generic self-administered testosterone cypionate injections are typically the most affordable cash-pay option, often $30 to $100 per month before supplies and visits. Pharmacy discount programs, HSA/FSA funds, and bundled telehealth memberships can further reduce out-of-pocket costs.

Bottom Line: Is TRT Covered by Insurance for You?

For most men with clinically documented low testosterone and qualifying symptoms, the answer is yes, with the standard prior authorization process. Aetna, BCBS, Cigna, and UnitedHealthcare all generally cover TRT when medical necessity is established, though formulary tiers and preferred medications vary. Medicare can cover therapy through Part B or Part D, with the major caveat that age-related low testosterone often falls outside its coverage rules. Medicaid coverage is state-specific.

The practical takeaway: get your morning labs drawn on two separate days, work with a provider who knows how to document hypogonadism cleanly, and ask about prior authorization upfront. If your insurance won’t cover therapy, cash-pay generic injectables remain genuinely affordable for most budgets, and HSA or FSA funds can help.

If you’d rather skip the insurance paperwork entirely and start treatment quickly, PrescribedRX offers a streamlined telehealth path. Their licensed clinicians evaluate your labs and symptoms, then design a treatment plan with transparent monthly pricing and ongoing monitoring built in. It can be a sensible next step worth considering, especially if you’ve been stuck in prior authorization limbo or your levels fall just above your insurer’s threshold.

Ready to take the next step?

Book a TRT consultation with PrescribedRX to talk with a licensed clinician about your labs, symptoms, and the right treatment path for you.

---

PrescribedRX sells its own treatments, so we compete with some of the companies covered here, and we may earn affiliate commissions. Content is informational and does not constitute medical advice. Always consult a licensed physician before starting, stopping, or changing any treatment plan.

What the Carriers Actually Say, in Their Own Words

Insurer policies are public documents. Rather than paraphrase them, here is what three of them state directly, with the version dates, so you can check them against whatever your plan sends you.

• Aetna. Clinical Policy Bulletin 1014 (last reviewed 13 July 2026) requires “at least two confirmed low morning testosterone levels” and lists age-related or late-onset hypogonadism as experimental, investigational or unproven.
• Cigna. Injectable prior-authorisation policy cnf_620 (revised 17 September 2025) requires “two pretreatment serum testosterone (total or bioavailable) measurements, each taken in the early morning, on two separate days.”
• Cigna, oral, topical and nasal policy IP0350 (effective 15 June 2026) references a total testosterone level below 300 ng/dL.

One detail worth knowing: the widely quoted 300 ng/dL figure is not a universal rule. Aetna’s bulletin and Cigna’s injectable policy both define “low” against the laboratory’s own reference range rather than a fixed number. Cigna’s oral and topical policy does use 300. Which one applies to you depends on your plan and your formulation.

Neither Cigna policy we reviewed contains an age-related exclusion at all. The only excluded use quoted is to enhance athletic performance.

The Gap Between the FDA and Your Insurer

This is the single most useful thing to understand if you are facing a denial.

In June 2026 the FDA requested removal of the long-standing labeling limitation that said safety and efficacy in men with age-related hypogonadism had not been established. That limitation had been the usual rationale for excluding age-related low testosterone from coverage.

Payer policy has not followed. Aetna’s bulletin was last reviewed on 13 July 2026 (a month after the FDA change), and still lists age-related hypogonadism as experimental and investigational. If your denial letter leans on the old FDA language, that is worth raising in an appeal, with the June 2026 update attached.

What still stands is narrower: testosterone products remain approved only for men with low testosterone in conjunction with an associated medical condition. A documented underlying cause still matters. The change is that “age-related” is no longer disqualifying on the label itself.

Start with PrescribedRX

PrescribedRX offers testosterone replacement therapy online. You start with a comprehensive lab panel at Quest and a video visit with a US-licensed provider, and you are billed for treatment only if a provider approves you. Check your eligibility.

References

1. Aetna Clinical Policy Bulletin 1014: Testosterone Cypionate Injections. Last reviewed 13 July 2026. Aetna CPB 1014
2. Aetna Pharmacy Prior Authorization Policy 976-A (Testosterone / Depo-Testosterone), UDR 03-2024. Aetna PA 976-A
3. Cigna Coverage Policy cnf_620: Testosterone Injectable Products, Prior Authorization. Revised 17 September 2025. Cigna cnf_620 (PDF)
4. Cigna Coverage Policy IP0350: Testosterone Oral, Topical and Nasal. Effective 15 June 2026. Cigna IP0350 (PDF)
5. U.S. Department of Health and Human Services. FDA Requests Updates to Testosterone Therapy Labeling. 18 June 2026. HHS
6. U.S. Food and Drug Administration. Testosterone Information. FDA
7. Medicare.gov. Medicare costs. Medicare.gov

Insurer policies are revised frequently. Every policy above is cited with its version date. Check the current version before relying on it. Coverage claims for Blue Cross Blue Shield and UnitedHealthcare on this page reflect general industry practice rather than a specific published policy document. Last reviewed August 2026.

Related reading

More on testosterone therapy:

• TRT guide
• Is TRT safe
• TRT dosage guide
• Does TRT work
• How long does TRT take to work
• TRT methods comparison
• TRT heart health
• Hcg on TRT
• TRT estrogen management

Plans from PrescribedRX

PrescribedRX prescribes through clinicians licensed in your state. Plans in this category:

• Injectable Testosterone
• Testosterone Cream
• Enclomiphene

Every plan and its current price is on the plans page and the pricing page.

This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.